Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relmada Therapeutics (RLMD) Non-Current Assets (2016 - 2026)

Relmada Therapeutics has reported Non-Current Assets over the past 2 years, most recently at $1250.0 for Q1 2014.

  • Quarterly Non-Current Assets changed N/A to $1250.0 in Q1 2014 from the year-ago period, while the trailing twelve-month figure was $5900.0 through Feb 2014, changed N/A year-over-year, with the annual reading at $1550.0 for FY2013, N/A changed from the prior year.
  • Non-Current Assets was $1250.0 for Q1 2014 at Relmada Therapeutics, down from $1400.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1700.0 in Q2 2013 and troughed at $1250.0 in Q1 2014.